Lumida
/TSHA
⌘K
Taysha Gene Therapies Inc

Taysha Gene Therapies Inc

TSHA
$5.96USD-0.17%-0.01 today

MARKET CAP

1.9B

P/E (TTM)

FWD P/E

DAY RANGE

$6 – $6

52W RANGE

$2
$7

AI Summary

Stalk
Sell NowMedium

TSHA is in a Stage 4 decline with medium-term bearish tradability supported by a Lower Highs & Lower Lows pattern and recent price rejection at the 9/20/50 EMA cluster. Short-term execution favors selling now amid persistent downward momentum. Long-term uptrend remains intact above the 200 DMA but is secondary to the current decline.

  • 100% patient response in early TASHA-102 trials achieving key milestones.
  • Breakthrough therapy designation from FDA streamlines regulatory approval process.
  • Net loss of $109M in 2025 widens operating deficits.
Full analysis →
Insider Trades15 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jul 10, 2026SellTSHASukumar NagendranPresident and Head of R&D200,000$6.24$1.9B-18.36%+154.70%$1.2M-17.60%10b5-1Sell Now
Apr 10, 2026SellTSHASukumar NagendranPresident and Head of R&D219,021$4.22$1.9B-18.36%+154.70%$924.5K-5.82%10b5-1Sell Now
Feb 4, 2026SellTSHAKamran AlamCHIEF FINANCIAL OFFICER1,655$4.52$1.9B-18.36%+154.70%$7.5K-0.11%Sell Now
Jan 23, 2026SellTSHAKamran AlamCHIEF FINANCIAL OFFICER102,817$4.72$1.9B-18.36%+154.70%$485.0K-3.41%Sell Now
Jan 23, 2026SellTSHASukumar NagendranPresident and Head of R&D116,050$4.72$1.9B-18.36%+154.70%$547.5K-4.18%Sell Now
Jan 23, 2026SellTSHASean P. NolanChief Executive Officer178,101$4.72$1.9B-18.36%+154.70%$840.2K-2.95%Sell Now
Jan 12, 2026SellTSHASukumar NagendranPresident and Head of R&D400,000$2.93$1.9B-18.36%+154.70%$1.2M+0.00%10b5-1Sell Now
Nov 28, 2025SellTSHASukumar NagendranPresident and Head of R&D740,344$3.05$1.9B-18.36%+154.70%$2.3M+0.00%Sell Now
Sep 10, 2025SellTSHASukumar NagendranPresident and Head of R&D241,150$2.80$1.9B-18.36%+154.70%$674.8K-5.96%10b5-1Sell Now
Aug 21, 2025SellTSHAKamran AlamCHIEF FINANCIAL OFFICER54,491$2.85$1.9B-18.36%+154.70%$155.3K-4.39%Sell Now
Aug 21, 2025SellTSHASukumar NagendranPresident and Head of R&D57,054$2.85$1.9B-18.36%+154.70%$162.6K-4.67%Sell Now
Mar 11, 2025SellTSHAKamran AlamCHIEF FINANCIAL OFFICER29,843$1.69$1.9B-18.36%+154.70%$50.4K-2.35%Sell Now
Feb 2, 2024SellTSHAKamran AlamCHIEF FINANCIAL OFFICER1,288$1.51$1.9B-18.36%+154.70%$1.9K-0.15%Sell Now
Aug 24, 2023SellTSHAKamran AlamChief Financial Officer33,000$2.33$1.9B-18.36%+154.70%$76.9K-11.34%10b5-1Sell Now
Aug 16, 2023BuyTSHASean P. NolanChief Executive Officer444,444$0.90$1.9B-18.36%+154.70%$400.0K+40.73%Sell Now